Tumour Markers in Testicular Germ Cell Tumours Five-Year Experience from the DATECA Study 1976–1980
- 1 January 1984
- journal article
- research article
- Published by Taylor & Francis in Acta Radiologica: Oncology
- Vol. 23 (4) , 287-294
- https://doi.org/10.3109/02841868409136024
Abstract
Since Jan. 1, 1976, nearly all new cases of testicular germ cell tumours have been included in the Danish Testicular Carcinoma Study (DATECA), and have been monitored by the tumour markers alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG). During the first five years, 1058 patients participated in the investigation, but only 603 of these patients were followed by preoperative as well as postoperative marker determinations in serum. The overall prevalence of marker positivity, i.e. elevated preoperative values for AFP and/or HCG, was 8 per cent for seminoma patients and 60 per cent for nonseminoma patients. Elevated levels of serum AFP and HCG were correlated to the presence of endodermal sinus tumour and choriocarcinoma elements, respectively, in the primary tumour. The presence of increased marker concentration in serum was correlated to stage (higher percentage in higher stages) and to prognosis (marker negative patients had a better prognosis than marker positive patients). Marker production by seminoma patients seems to indicate a poor prognosis, especially for HCG producing seminomas.This publication has 15 references indexed in Scilit:
- Non-Seminomatous Testicular Germ Cell Tumours in Denmark 1976–1980 Results of TreatmentActa Radiologica: Oncology, 1984
- Testicular Seminoma in Denmark 1976–1980 Results of TreatmentActa Radiologica: Oncology, 1984
- Testicular Carcinoma in Denmark 1976–1980 Stage and Selected Clinical Parameters at PresentationActa Radiologica: Oncology, 1984
- Non-Seminomatous Testicular Germ Cell Tumours: Preliminary analysis of ongoing trials in the Dateca StudyActa Radiologica: Oncology, 1984
- Testicular Germ-Cell Neoplasms: Recent Advances in Diagnosis and TherapyAnnals of Internal Medicine, 1979
- The Role of Alphafetoprotein and Human Chorionic Gonadotropin in SeminomaJournal of Urology, 1978
- Serum alpha-fetoprotein and human chorionic gonadotropin as markers for the effect of postoperative radiation therapy and/or chemotherapy in testicular cancerCancer, 1978
- CLINICAL USE OF A.F.P. AND H.C.G. IN TESTICULAR TUMOURS OF GERM-CELL ORIGINThe Lancet, 1978
- The Value of Serum Tumor Markers in the Staging and Prognosis of Germ Cell Tumors of the TestisJournal of Urology, 1977
- SERUM-ALPHA1-FETOPROTEIN IN PATIENTS WITH TESTICULAR TUMOURSThe Lancet, 1976